Effects of transfusion on immune function. Cancer recurrence and infection
- PMID: 8166587
Effects of transfusion on immune function. Cancer recurrence and infection
Abstract
The paradigm related to the immunologic consequences of allogeneic blood transfusions has been extended from humoral allosensitization to the effects of transfusion on cellular immune function. This includes downregulation of effector cells, activation of latent viral infection, and the prolonged circulation of donor immunocompetent cells, as seen in graft-vs-host disease. There are now extensive data showing conclusively that allogeneic transfusions are associated with increases in cancer recurrence rates (80% in colorectal cancer) and postoperative bacterial infections (as much as 200% to 1000% in some studies). Whether these associations are causal or not remains in doubt. Based on animal and clinical studies, we believe these associations are likely, in part, due to immune dysregulation caused by transfusion, perhaps augmented by the effects of hemorrhage, anesthesia, and surgical stress. The most likely mechanism underlying transfusion-induced immunosuppression is anergy due to presentation of large amounts of antigen through the intravenous route. This favors presentation of antigen by "nonprofessional" antigen-presenting cells, a situation that usually leads to anergy or tolerance rather than immune activation. Two additional hypothetical mechanisms proposed for immune dysregulation after allogeneic transfusion are (1) prolonged circulation of donor cells causing subclinical graft-vs-host disease, and (2) reactivation of immunosuppressive viruses latently present in recipient white blood cells. Results of some initial interventional studies, employing autologous transfusions or removing white blood cells from allogenic donor blood suggest that relatively simple, cost-effective strategies to ameliorate these complications may be at hand.
Similar articles
-
Transfusion-induced immunomodulation and its possible role in cancer recurrence and perioperative bacterial infection.Yale J Biol Med. 1990 Sep-Oct;63(5):429-33. Yale J Biol Med. 1990. PMID: 2293502 Free PMC article. Review.
-
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.Dan Med Bull. 2007 May;54(2):112-39. Dan Med Bull. 2007. PMID: 17521527 Review.
-
Transfusion and recipient immune function.Arch Pathol Lab Med. 1989 Mar;113(3):246-53. Arch Pathol Lab Med. 1989. PMID: 2645852 Review.
-
Immunologic aspects of blood transfusion.Semin Oncol. 1994 Apr;21(2 Suppl 3):16-20. Semin Oncol. 1994. PMID: 8202721 Review.
-
Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.Int Immunopharmacol. 2003 Aug;3(8):1121-43. doi: 10.1016/S1567-5769(03)00014-6. Int Immunopharmacol. 2003. PMID: 12860168 Review.
Cited by
-
Noncausal relationship between cancer recurrence and perioperative blood transfusions.Ann Surg. 1995 Dec;222(6):757-8. doi: 10.1097/00000658-199512000-00010. Ann Surg. 1995. PMID: 8526582 Free PMC article. No abstract available.
-
Perioperative Blood Transfusion Promotes Worse Outcomes of Bladder Cancer after Radical Cystectomy: A Systematic Review and Meta-Analysis.PLoS One. 2015 Jun 16;10(6):e0130122. doi: 10.1371/journal.pone.0130122. eCollection 2015. PLoS One. 2015. PMID: 26080092 Free PMC article. Review.
-
Intravenous delivery of the plasma fraction of stored packed erythrocytes promotes pancreatic cancer growth in immunocompetent mice.Cancer. 2010 Aug 15;116(16):3862-74. doi: 10.1002/cncr.25140. Cancer. 2010. PMID: 20564095 Free PMC article.
-
A Novel Nomogram for Prediction of Early Postoperative Complications of Total Gastrectomy for Gastric Cancer.Cancer Manag Res. 2021 Oct 2;13:7579-7591. doi: 10.2147/CMAR.S333172. eCollection 2021. Cancer Manag Res. 2021. PMID: 34629904 Free PMC article.
-
A national analysis on complications and readmissions for adult cerebral palsy patients undergoing primary spinal fusion surgery.Eur Spine J. 2022 Mar;31(3):718-725. doi: 10.1007/s00586-021-07089-4. Epub 2022 Jan 24. Eur Spine J. 2022. PMID: 35067761
Publication types
MeSH terms
LinkOut - more resources
Medical